Lucid Diagnostics Return on Equity

Lucid Diagnostics (LUCD) currently reports a ROE of -2023565.1%. That is below the sector sector average of -5.87%. Use the charts on this page to explore Lucid Diagnostics's ROE history and peer comparisons.

Lucid Diagnostics's ROE of -2023565.1% is lower than the its sector sector average of -5.87%. That is roughly 34481572.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Lucid Diagnostics's current -2023565.1% should be judged against industry norms (sector average: -5.87%) and against LUCD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -2023565.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.87%. From there, open related valuation or income-statement pages for Lucid Diagnostics, and consider following LUCD for alerts when major investors trade the stock.